WallStreetZenWallStreetZen

NASDAQ: VIGL
Vigil Neuroscience Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VIGL

Based on 4 analysts offering 12 month price targets for Vigil Neuroscience Inc.
Min Forecast
$16.00+323.28%
Avg Forecast
$19.75+422.49%
Max Forecast
$23.00+508.47%

Should I buy or sell VIGL stock?

Based on 4 analysts offering ratings for Vigil Neuroscience Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VIGL stock forecasts and price targets.

VIGL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-14
lockedlocked$00.00+00.00%2024-08-14
lockedlocked$00.00+00.00%2024-07-11
lockedlocked$00.00+00.00%2024-04-19

1 of 1

Forecast return on equity

Is VIGL forecast to generate an efficient return?
Company
-63.85%
Industry
-402.71%
Market
58.16%
VIGL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VIGL forecast to generate an efficient return on assets?
Company
-50.2%
Industry
26.38%
VIGL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VIGL earnings per share forecast

What is VIGL's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$2.15
Avg 2 year Forecast
-$2.03
Avg 3 year Forecast
-$1.60

VIGL revenue forecast

What is VIGL's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$70.3M
Avg 2 year Forecast
$62.5M
Avg 3 year Forecast
$184.5M

VIGL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VIGL$3.78$19.75+422.49%Strong Buy
ADVM$7.18$28.17+292.30%Strong Buy
ABOS$2.51$9.33+271.83%Strong Buy
ACHV$4.30$15.50+260.47%Strong Buy
VTYX$2.17$10.25+372.35%Strong Buy
View Top Biotech Stocks

Vigil Neuroscience Stock Forecast FAQ

Is Vigil Neuroscience Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: VIGL) stock is to Strong Buy VIGL stock.

Out of 4 analysts, 1 (25%) are recommending VIGL as a Strong Buy, 3 (75%) are recommending VIGL as a Buy, 0 (0%) are recommending VIGL as a Hold, 0 (0%) are recommending VIGL as a Sell, and 0 (0%) are recommending VIGL as a Strong Sell.

If you're new to stock investing, here's how to buy Vigil Neuroscience stock.

What is VIGL's earnings growth forecast for 2024-2026?

(NASDAQ: VIGL) Vigil Neuroscience's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.98%.

Vigil Neuroscience's earnings in 2024 is -$83,836,000.On average, 5 Wall Street analysts forecast VIGL's earnings for 2024 to be -$85,162,901, with the lowest VIGL earnings forecast at -$96,343,505, and the highest VIGL earnings forecast at -$76,916,214. On average, 5 Wall Street analysts forecast VIGL's earnings for 2025 to be -$80,325,902, with the lowest VIGL earnings forecast at -$86,431,622, and the highest VIGL earnings forecast at -$68,590,232.

In 2026, VIGL is forecast to generate -$63,336,934 in earnings, with the lowest earnings forecast at -$86,035,147 and the highest earnings forecast at -$22,995,569.

What is VIGL's revenue growth forecast for 2026-2028?

(NASDAQ: VIGL) Vigil Neuroscience's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.32%.

Vigil Neuroscience's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast VIGL's revenue for 2026 to be $2,785,239,193, with the lowest VIGL revenue forecast at $2,785,239,193, and the highest VIGL revenue forecast at $2,785,239,193. On average, 3 Wall Street analysts forecast VIGL's revenue for 2027 to be $2,477,019,272, with the lowest VIGL revenue forecast at $733,479,361, and the highest VIGL revenue forecast at $4,618,937,595.

In 2028, VIGL is forecast to generate $7,313,582,175 in revenue, with the lowest revenue forecast at $5,963,385,439 and the highest revenue forecast at $8,663,778,911.

What is VIGL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VIGL) forecast ROA is -50.2%, which is lower than the forecast US Biotechnology industry average of 26.38%.

What is VIGL's Price Target?

According to 4 Wall Street analysts that have issued a 1 year VIGL price target, the average VIGL price target is $19.75, with the highest VIGL stock price forecast at $23.00 and the lowest VIGL stock price forecast at $16.00.

On average, Wall Street analysts predict that Vigil Neuroscience's share price could reach $19.75 by Aug 14, 2025. The average Vigil Neuroscience stock price prediction forecasts a potential upside of 422.49% from the current VIGL share price of $3.78.

What is VIGL's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: VIGL) Vigil Neuroscience's current Earnings Per Share (EPS) is -$2.12. On average, analysts forecast that VIGL's EPS will be -$2.15 for 2024, with the lowest EPS forecast at -$2.43, and the highest EPS forecast at -$1.94. On average, analysts forecast that VIGL's EPS will be -$2.03 for 2025, with the lowest EPS forecast at -$2.18, and the highest EPS forecast at -$1.73. In 2026, VIGL's EPS is forecast to hit -$1.60 (min: -$2.17, max: -$0.58).

What is VIGL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VIGL) forecast ROE is -63.85%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.